Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Hemostats For Wound Closure Market Globally Expected to Drive Growth through 2025




(PharmaNewsWire.Com, January 03, 2017 ) Historically wound types remain the same over the ages with only a slight exception being the emergence of femoral punctures associated with catheterization procedures. But with the advent of newer technologies the practice of closing those wounds are changed.

These new products are commonly available on hospitals & trauma centers and have wide range of usage area. Among them Hemostat has become a very popular tool to be used as wound closure material with its excellent properties. When applied to a wound, quickly absorbs blood and other body fluids, transforms into a gel to seal the wound with a protective transparent layer, actively aids in stopping bleeding, and creates an environment for wound healing.

Treatment of damaged cardiac tissue in patients with high bleeding tendency can be very challenging. In this category of surgery Hemostat proved to be a very effective with the combination of collagen sponge for the management of a myocardial wound

Topical hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-827

Hemostats for Wound Closure: Drivers and Restraints

Wound closure has become a very frequent clinical practice which is growing very rapidly. The sophisticated procedures ensure rapid cessation of blood loss, prompt closure, strong adhesion of wound edges, tight sealing, reduced scarring, reduced risk of infection and more rapid healing. There is a pool of patients throughout the world which makes the market of this product is very lucrative. As the price is also very reasonable so acceptance of this product is gradually progressing.

On the other hand some reports come which could restrict the growth. Surgical staples are emerging as the most useful tool on this wound closure segment. Also the market of suture which is there traditionally remains constant if not growing to some parts of the world. Few reports also suggested that patients may suffer with irritation, heat inflammation or redness on skin when hemostat are applied, though its not clear the exact reason for these.

As the market is growing and price is low, so tough competitions will prevail in this segment too.

Hemostats for Wound Closure: Segmentation

Global market for wound closure products consist of hemostat are mainly driven the use of Fibrin which is the combination of thrombin & fibrinogen. Also collagen finds it use as hemostat though it still needs the approval of USFDA.

Thrombin based Hemostats
Combination Hemostats
Oxidized Regenerated Cellulose Hemostats
Gelatin Hemostats
Collagen based Hemostats
Hemostats for Wound Closure: Overview

With the rapid technological advancement in healthcare industry the Hemostats is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-827

Hemostats for Wound Closure: Region-wise Outlook

Geographically, the wound closure products market has been segmented into seven major geographical regions which include North America, Eastern Europe, Western Europe, Asia Pacific exclude Japan, Japan & Latin America, Middle east & Africa. North America contribute the most in this market followed by Europe. With the new product approvals, change in regulatory policies encourages, patient acceptance helps the market to grow. Asia Pacific & Japan pose good growth potential too for wound closure products specially Hemostat.

Hemostats for Wound Closure: Key Players

Wound closure product market is highly fragmented with presence of big & small companies. The market leaders in this area are Johnson & Johnson, Covidien, B. Braun, and 3M.



Future Market Insights

Abhishek Budholiya

2076928790

abhishek.b@futuremarketinsights.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC